# DIEBOLD NIXDORF, Inc: Form 10-Q for the period ended Mar 31, 2025

- Company: [DIEBOLD NIXDORF, Inc](/companies/dbd.md) (CIK 28823)
- Form: 10-Q
- Filed: 2025-05-07
- Accepted by EDGAR: May 7, 2025, 16:35 ET
- Period: 2025-03-31
- Accession: 0000028823-25-000057
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/28823/000002882325000057/dbd-20250331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/28823/000002882325000057/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-01-01 to 2025-03-31 | $841.1m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2025-01-01 to 2025-03-31 | $638.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2025-01-01 to 2025-03-31 | $202.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2025-01-01 to 2025-03-31 | $22.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2025-01-01 to 2025-03-31 | $151.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2025-01-01 to 2025-03-31 | $29.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-01-01 to 2025-03-31 | $21.5m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2025-01-01 to 2025-03-31 | −$2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-01-01 to 2025-03-31 | −$8.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-01-01 to 2025-03-31 | −$0.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-01-01 to 2025-03-31 | −$0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-01-01 to 2025-03-31 | 37,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2025-01-01 to 2025-03-31 | $15.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 3 months, 2025-01-01 to 2025-03-31 | $9.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-03-31 | $306.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-03-31 | $1.73bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-03-31 | $3.63bn | us-gaap:Assets |
| Current liabilities | at 2025-03-31 | $1.28bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-03-31 | $2.63bn | us-gaap:Liabilities |
| Long-term debt | at 2025-03-31 | $928.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-03-31 | $300.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2025-03-31 | $984.0m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/28823/000002882325000057/dbd-20250331.htm

Filed May 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000028823-25-000057. Last ingested by Listed: Oct 28, 2026, 07:18 ET. No prices; not investment advice.
